补肾健脾汤联合左卡尼汀治疗慢性肾衰竭临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R692.5

基金项目:


Clinical Study on Bushen Jianpi Tang Combined with L- Carnitine for Chronic Renal Failure
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察补肾健脾汤联合左卡尼汀治疗慢性肾衰竭(CRF) 的临床疗效。方法:将100 例CRF患者随机分为观察组和对照组各50 例,对照组采用静脉注射左卡尼汀注射剂治疗,观察组在对照组基础上联合补肾健脾汤辨证治疗。比较2 组临床疗效及治疗前后的主要症状积分、肾功能指标、炎症因子水平,并记录治疗过程中不良反应发生情况。结果:观察组临床总有效率86.00%,高于对照组64.00% (P<0.05)。治疗前,2 组主要症状积分比较,差异无统计学意义(P>0.05);治疗后,2 组主要症状积分均降低(P<0.05),且观察组低于对照组(P<0.05)。治疗前,2 组血尿素氮(BUN)、血清肌酐(SCr)、肌酐清除率(CCr)、24 h尿蛋白定量水平比较,差异无统计学意义(P>0.05);治疗后,2 组BUN、SCr、24 h 尿蛋白定量水平均降低(P<0.05),CCr 升高(P<0.05),且观察组BUN、SCr、24 h 尿蛋白定量水平低于对照组(P<0.05),CCr高于对照组(P<0.05)。治疗前,2 组白细胞介素-6 (IL-6)、肿瘤坏死因子-α (TNF-α) 及超敏C-反应蛋白(hs-CRP)水平比较,差异无统计学意义(P>0.05);治疗后,2 组IL-6、TNF-α、hs-CRP 水平均降低(P<0.05),且观察组低于对照组(P<0.05)。2 组不良反应比较,差异无统计学意义(P>0.05)。结论:采用补肾健脾汤辨证施治联合左卡尼汀治疗CRF 患者可明显提高治疗效果,改善患者的主要中医症状、肾功能和微炎症状态,延缓疾病进展,且具有较好的安全性。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Bushen Jianpi Tang combined with L- carnitine for chronic renal failure(CRF). Methods:A total of 100 cases of CRF patients were randomly divided into the observation group and the control group,with 50 cases in each group. The control group was treated with L- carnitine,and the observation group was treated with L- carnitine combined with Bushen Jianpi Tang. The scores of main symptoms,the indexes of kidney function and the levels of inflammatory factors before and after treatment as well as the clinical effects were compared between the two groups;the incidence of adverse reactions during treatment was recorded. Results:The total clinical effective rate was 86.00% in the observation group,higher than that of 64.00% in the control group(P<0.05). Before treatment,there was no significant difference being found in the comparison of the scores of main symptoms between the two groups(P>0.05). After treatment,the scores of main symptoms in the two groups were decreased(P< 0.05), and the score in the observation group was lower than that in the control group(P<0.05). Before treatment, there was no significant difference being found in the comparison of the levels of blood urea nitrogen(BUN),serum creatinine(SCr),creatinine clearance rate(CCr) and 24- hour urine protein excretion between the two groups(P>0.05). After treatment, the levels of BUN, SCr and 24- hour urine protein excretion in the two groups were decreased(P<0.05), and CCr was increased(P<0.05); the levels of BUN, SCr and 24- hour urine protein excretion in the observation group were lower than those in the control group(P<0.05), and CCr was higher(P<0.05). Before treatment, there was no significant difference being found in the comparison of the levels of interleukin- 6(IL- 6), tumor necrosis factor- α (TNF-α) and high-sensitivity C-reactive protein(hs-CRP) between the two groups(P>0.05). After treatment, the levels of IL-6,TNF-α and hs-CRP in the two groups were decreased(P<0.05),and the above levels in the observation group were lower than those in the control group(P<0.05). There was no significant difference being found in the comparison of adverse reactions between the two groups(P>0.05). Conclusion:The therapy of Bushen Jianpi Tang combined with L-carnitine for CRF patients can significantly enhance the curative effect,improve the main Chinese medicine symptoms,kidney function and microinflammation status and delay the disease progression,with good safety.

    参考文献
    相似文献
    引证文献
引用本文

郑栓,郑建国,程宁宁,王东海.补肾健脾汤联合左卡尼汀治疗慢性肾衰竭临床研究[J].新中医,2022,54(23):98-102

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-12-11
  • 出版日期:
文章二维码